Company

Amount

Number of Shares

Share Price

Discount

Placement Agent

Advanced Viral Research Corp.

1



0.3

The company placed a 7% 10-year convertible debenture with the RBB Bank of Aus- tria; the debenture is convert- ible into common shares at 700f market; the company also issued to RBB Bank war- rants to buy 0.54M common shares at $0.29-$0.84 each (3/97)

Glyko Biomedical Ltd. (TSE:GBL)

1.5

ND

ND

ND

Glyko Biomedical raised $1.5M through a Reg.S offer- ing of an undisclosed number of units to a European invest- or group; Clubb BioCapital of London acted as the agent; the money represents the initial financing for Glyko¿s pharmaceutical subsidiary BioMarin Pharmaceuticals Inc. (funds converted at an exchange rate of C$1.37/US $1.00) (3/97)


No Comments